Cargando…

Urine- and Blood-Based Molecular Profiling of Human Prostate Cancer

OBJECTIVE: Prostate cancer (PCa) is one of the most common malignant tumors, accounting for 20% of total tumors ranked first in males. PCa is usually asymptomatic at the early stage and the specificity of the current biomarkers for the detection of PCa is low. The present study evaluates circulating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Gang, Jia, Guojin, Chao, Fan, Xie, Feng, Zhang, Yue, Hou, Chuansheng, Huang, Yong, Tang, Haoran, Yu, Jianjun, Zhang, Jihong, Jia, Shidong, Xu, Guoxiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984469/ https://www.ncbi.nlm.nih.gov/pubmed/35402245 http://dx.doi.org/10.3389/fonc.2022.759791

Ejemplares similares

Clinicopathological signature of p21-activated kinase 1 in prostate cancer and its regulation of proliferation and autophagy via the mTOR signaling pathway
por: Wang, Zhanyu, et al.
Publicado: (2017)

Alpha-L-Fucosidase Has Diagnostic Value in Prostate Cancer With “Gray-Zone PSA” and Inhibits Cancer Progression via Regulating Glycosylation
por: Zhang, Cong, et al.
Publicado: (2021)

Circulating Cell-Free DNA-Based Detection of Tumor Suppressor Gene Copy Number Loss and Its Clinical Implication in Metastatic Prostate Cancer
por: Dong, Xiaoxi, et al.
Publicado: (2021)

Clinicopathologic features, genomic profiles and outcomes of younger vs. older Chinese hormone receptor-positive (HR+)/HER2-negative (HER2-) metastatic breast cancer patients
por: Wang, Jinhao, et al.
Publicado: (2023)

Germline Mutational Landscape in Chinese Patients With Advanced Breast Cancer
por: Zhang, Jiayang, et al.
Publicado: (2022)

LC–MS-Based Urine Metabolomics Analysis for the Diagnosis and Monitoring of Medulloblastoma
por: Liu, Xiaoyan, et al.
Publicado: (2022)

Integrin Alpha V in Urine: A Novel Noninvasive Marker for Prostate Cancer Detection
por: Zemskova, Marina Y., et al.
Publicado: (2021)

Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy
por: Jin, Xin, et al.
Publicado: (2022)

Gonadotropin-releasing hormone agonist protects ovarian function in young patients with ovarian malignancy undergoing platinum-based chemotherapy: A prospective study
por: Xie, Ya, et al.
Publicado: (2022)

Metastatic bladder tumor from prostate cancer causing a ball valve-like obstruction in urination
por: Imanaka, Takahiro, et al.
Publicado: (2020)

Deep Learning-Based Multi-Omics Integration Robustly Predicts Relapse in Prostate Cancer
por: Wei, Ziwei, et al.
Publicado: (2022)

Evaluation of the diagnostic efficiency of voided urine fluorescence in situ hybridization for predicting the pathology of preoperative “low-risk” upper tract urothelial carcinoma
por: Xu, Ben, et al.
Publicado: (2023)

Metabolomics Profiling Discriminates Prostate Cancer From Benign Prostatic Hyperplasia Within the Prostate-Specific Antigen Gray Zone
por: Xu, Bei, et al.
Publicado: (2021)

HNRNPC Promotes Proliferation, Metastasis and Predicts Prognosis in Prostate Cancer
por: Wang, Shiyu, et al.
Publicado: (2021)

Development of a novel nomogram for predicting clinically significant prostate cancer with the prostate health index and multiparametric MRI
por: Mo, Li-Cai, et al.
Publicado: (2022)

The Emerging Role of Circular RNAs in Prostate Cancer: A Systematic Review
por: Chao, Fan, et al.
Publicado: (2021)

Comparing the Survival Outcomes of Radical Prostatectomy Versus Radiotherapy for Patients With De Novo Metastasis Prostate Cancer: A Population-Based Study
por: Guo, Xiaoxiao, et al.
Publicado: (2021)

Offsetting Expression Profiles of Prognostic Markers in Prostate Tumor vs. Its Microenvironment
por: Jia, Zhenyu, et al.
Publicado: (2019)

A four‐group urine risk classifier for predicting outcomes in patients with prostate cancer
por: Connell, Shea P., et al.
Publicado: (2019)

Breast mass as the first sign of metastasis from rectal carcinoma: a case report and review of the literature
por: Xu, Jiawei, et al.
Publicado: (2023)

Exploring the Potential of Pyroptosis-Related Genes in Predicting Prognosis and Immunological Characteristics of Pancreatic Cancer From the Perspective of Genome and Transcriptome
por: Zhang, Jing, et al.
Publicado: (2022)

Development of a Nomogram Based on Preoperative Bi-Parametric MRI and Blood Indices for the Differentiation Between Cystic-Solid Pituitary Adenoma and Craniopharyngioma
por: Zhao, Zhen, et al.
Publicado: (2021)

Urine Metabolomics for Renal Cell Carcinoma (RCC) Prediction: Tryptophan Metabolism as an Important Pathway in RCC
por: Liu, Xiaoyan, et al.
Publicado: (2019)

Can Routine Blood and Urine Parameters Reveal Clues to Detect Bladder Cancer? A Case–Control Study
por: Wang, Dan-Qi, et al.
Publicado: (2022)

Gene Expression Profiles Identified Novel Urine Biomarkers for Diagnosis and Prognosis of High-Grade Bladder Urothelial Carcinoma
por: Song, Yuxuan, et al.
Publicado: (2020)

Prediction of Biochemical Recurrence-Free Survival of Prostate Cancer Patients Leveraging Multiple Gene Expression Profiles in Tumor Microenvironment
por: Zhou, Rui, et al.
Publicado: (2021)

Prognostic Value of Androgen Receptor Splice Variant 7 in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
por: Wang, Jiaxin, et al.
Publicado: (2020)

Detecting and monitoring bladder cancer with exfoliated cells in urine
por: Li, Nannan, et al.
Publicado: (2022)

Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis
por: Tian, Xiaoling, et al.
Publicado: (2015)

Serum Metabolic Profiling Identifies a Biomarker Panel for Improvement of Prostate Cancer Diagnosis
por: Xu, Huan, et al.
Publicado: (2021)

The Function of Fucosylation in Progression of Lung Cancer
por: Jia, Liyuan, et al.
Publicado: (2018)

Novel, alternative splicing signature to detect lymph node metastasis in prostate adenocarcinoma with machine learning
por: Xie, Ping, et al.
Publicado: (2023)

Clinical advancement of precision theranostics in prostate cancer
por: Tan, Yue, et al.
Publicado: (2023)

Prostate Microbiota and Prostate Cancer: A New Trend in Treatment
por: Che, Bangwei, et al.
Publicado: (2021)

Evaluation and multi-institutional validation of a novel urine biomarker lncRNA546 to improve the diagnostic specificity of prostate cancer in PSA gray-zone
por: Liu, Fei, et al.
Publicado: (2022)

Recent advances in oncolytic virus therapy for hepatocellular carcinoma
por: Zhu, Licheng, et al.
Publicado: (2023)

Prognostic values of ALDOB expression and (18)F-FDG PET/CT in hepatocellular carcinoma
por: Jia, Wenzhi, et al.
Publicado: (2022)

Detection and Segmentation of Pelvic Bones Metastases in MRI Images for Patients With Prostate Cancer Based on Deep Learning
por: Liu, Xiang, et al.
Publicado: (2021)

Drug Repurposing of Pantoprazole and Vitamin C Targeting Tumor Microenvironment Conditions Improves Anticancer Effect in Metastatic Castration-Resistant Prostate Cancer
por: Li, Zhoulei, et al.
Publicado: (2021)

LC-MS based urine untargeted metabolomic analyses to identify and subdivide urothelial cancer
por: Yang, Ming, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bn11oap89mgea9t0i5ltsdf00i